BlackRock
SPHS

BlackRock’s Sophiris Bio, Inc. SPHS Stock Holding History

BlackRock’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-72,220
Closed -$72K – 5193
2019
Q1 		$72K Sell
72,220
-4,620
-6% -$4.96K ﹤0.01% 4431
2018
Q4 		$64K Sell
76,840
-5,748
-7% -$11.3K ﹤0.01% 4438
2018
Q3 		$231K Buy
82,588
+3,357
+4% +$9.56K ﹤0.01% 4287
2018
Q2 		$223K Buy
79,231
+2,154
+3% +$6.4K ﹤0.01% 4282
2018
Q1 		$155K Sell
77,077
-1,970
-2% -$4.27K ﹤0.01% 4260
2017
Q4 		$179K Buy
79,047
+3,152
+4% +$6.86K ﹤0.01% 4232
2017
Q3 		$163K Sell
75,895
-4,334
-5% -$8.98K ﹤0.01% 4269
2017
Q2 		$177K Buy
+80,229
New +$197K ﹤0.01% 4282

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BO
BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BlackRock's SPHS Position: Q2 2019 in Review

BlackRock sold out of Sophiris Bio, Inc. (SPHS) in Q2 2019, closing a stake of 72,220 shares — an estimated $72K sold.

BlackRock first reported a position in SPHS in Q2 2017 and held it in 8 quarters. The position peaked at $231K in Q3 2018. 22 funds tracked by Wall St. Rank hold SPHS as of Q2 2019.

  • BlackRock reported no remaining Sophiris Bio, Inc. position as of Q2 2019 after selling out during the quarter.
  • BlackRock sold 72,220 Sophiris Bio, Inc. shares in Q2 2019, an estimated $72K.
  • BlackRock first reported a position in Sophiris Bio, Inc. in Q2 2017 and held it in 8 quarters.
  • BlackRock's Sophiris Bio, Inc. position peaked at $231K in Q3 2018.
  • 22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2019.

Based on BlackRock's 13F filing for Q2 2019, filed 13 Aug 2019.